遗传视网膜疾病的基因疗法:从实验室长椅到病人的床边和超越
Anand Singh Brar1, Deepika C Parameswarappa2, Brijesh Takkar2
1Anant Bajaj Retina Institute, LV Prasad Eye Institute, Mithu Tulsi Chanrai Campus, Bhubaneswar, 751024, India.
Ophthalmology and therapy
|December 19, 2023
概括
遗传性视网膜疾病 (IRD) 涉及遗传性视力丧失. 基因疗法为治疗提供了希望,尽管在优化和可访问性方面存在挑战,但正在进行的临床试验显示出有希望.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 遗传性视网膜疾病 (IRDs) 是一组多样化的遗传性疾病,导致因光受体细胞死亡而逐渐失去视力.
- 了解IRD复杂的遗传基础和多样化的遗传模式对于开发有效的治疗方法至关重要.
研究的目的:
- 提供对IRDs的分类,遗传基础和当前基因疗法格局的全面审查.
- 在IRD临床试验中强调各种基因疗法方法的潜力和挑战.
主要方法:
- 审查关于IRD分类和遗传学的现有文献.
- 对正在进行的基因治疗临床试验的分析,包括细胞替代,神经保护,药理学和光遗传学策略.
主要成果:
- 基因疗法为阻止或逆转IRD进展提供了一个有希望的途径.
- 目前的临床试验探讨了不同程度的成功和挑战的多种治疗方式.
- 关键的挑战包括优化治疗时间,标准化结果测量,管理炎症和完善传递载体.
结论:
- 基因疗法在治疗IRD方面具有重大潜力,为改善视力和生活质量提供了希望.
- 解决临床翻译,成本效益和视觉科学家之间更广泛的认识方面的挑战对于广泛采用至关重要.
- 持续的研究和强大的临床试验至关重要,以充分实现基因治疗对遗传视网膜疾病的治疗益处.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


